Comment by
jopatclo on Dec 17, 2021 12:50pm
This post has been removed in accordance with Community Policy
Comment by
chry200030 on Dec 17, 2021 12:55pm
Anything less than $10 a share would be disappointing. This should be worth between $30 - $50 per shares, so if we get a buyout for $15 - $25 per share, the buyer would double his money. Patience required.
Comment by
MoPeter on Dec 17, 2021 8:23pm
lol that's probably the most shamelessly high valuation I've seen yet. My guess is $2-300 billion for the company/ approx $1.30-2.00 per share and after 5 years I'd be happy to have it. I'd love to be wrong on the low end though, just don't see it unless they really come through with the sales
Comment by
LandCruiser1983 on Dec 18, 2021 10:32am
I think your .60cents is a lot closer to the truth than those wierdly high $+ valuations. Come back to reality,this is not a fantasy board. If we are not seeing any price increases during this peak Covid time,, (it is falling in S.P). it is not going to happen in the near 1-2 year future. This is our time to excell but we are floundering. JIHO.
Comment by
Pandora on Dec 18, 2021 12:29pm
Keep in mind that a few years back when they got the FDA approval the price ran from about 15 cents to 95 cents in about one hours time. (end of February, 2017?). It can be volatile with the right kind of news. Of course we have a boatload more shares mow.
Comment by
Pandora on Dec 19, 2021 12:16pm
Only thing I can say is too many deals with Chinese involvement have gone bust including a couple I had shares in -- never to be seen again. I would be much happier without a Chinese connection - but at this point it is what it is until we hear further.
Comment by
GrahamB on Dec 19, 2021 12:26pm
The concern always is a permanent "technology transfer" https://www.chinadaily.com.cn/a/202007/15/WS5f0e754fa310834817259993.html